Panel: Why Are We Not Doing Better? An Open Discussion of the Limitations of Current Drug Development for GBM and Where the Field Can Improve - Glioblastoma Drug Development

Panel: Why Are We Not Doing Better? An Open Discussion of the Limitations of Current Drug Development for GBM and Where the Field Can Improve

Time: 9:25 am

Details:

Barriers to advancing drug development and strategies to address these
Major therapeutic strategies currently under development
How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for GBM?